Overview
Peter Van Trigt Iii is a Thoracic Surgeon in Greensboro, North Carolina. Dr. Van Trigt Iii is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleuropulmonary Blastoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
301 E Wendover Ave Ste 411, Greensboro, NC 27401
1200 N Elm St, Greensboro, NC 27401
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT MD Anderson Cancer Center
Ara Vaporciyan is a Thoracic Surgeon in Cary, North Carolina. Dr. Vaporciyan is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Thrombectomy, and Nephrectomy.
UT MD Anderson Cancer Center
Jack Roth is a Thoracic Surgeon in Cary, North Carolina. Dr. Roth is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Endoscopy, and Thymectomy.
UT MD Anderson Cancer Center
David Rice is a Thoracic Surgeon in Cary, North Carolina. Dr. Rice is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymectomy, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Van Trigt Iii isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Van Trigt Iii isAdvanced. Learn about EGFR Positive Lung Cancer.
- Heart Bypass SurgeryDr. Van Trigt Iii isAdvanced. Learn about Heart Bypass Surgery.
- Lung AdenocarcinomaDr. Van Trigt Iii isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Van Trigt Iii isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Van Trigt Iii isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Arterial EmbolismDr. Van Trigt Iii isExperienced. Learn about Arterial Embolism.
- Collapsed LungDr. Van Trigt Iii isExperienced. Learn about Collapsed Lung.
- Coronary Artery Bypass Graft (CABG)Dr. Van Trigt Iii isExperienced. Learn about Coronary Artery Bypass Graft (CABG).
- EmphysemaDr. Van Trigt Iii isExperienced. Learn about Emphysema.
- Lung CancerDr. Van Trigt Iii isExperienced. Learn about Lung Cancer.
- Pleural EffusionDr. Van Trigt Iii isExperienced. Learn about Pleural Effusion.